Financials
- Market Capitalization 26.46 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.57
Rapporto prezzo/fatturato
-102.9
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4476 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.67 USD | +4.69% | -4.29% | -43.22% | -60.82% | 27.55 M USD | ||
| 4480 | NNVC NanoViricides, Inc. Common Stock | 1.24 USD | -3.88% | -5.34% | -19.48% | +22.76% | 26.84 M USD | ||
| 4491 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.58 USD | -2.27% | +0.78% | +17.81% | +239.47% | 25.75 M USD | ||
| 4501 | EVAX Evaxion A/S - American Depositary Share | 3.01 USD | -4.44% | -9.34% | +7.50% | -9.34% | 25.10 M USD |